Clinical significance and influencing factors of fibrinogen in ANCA-associated vasculitis A single-center retrospective study from Southwest China

被引:1
|
作者
Zhang, Naidan [1 ,2 ]
Sun, Jiaxiang [1 ]
Ji, Chaixia [1 ]
Zhou, Yusha [1 ]
Bao, Xiao [3 ]
Yuan, Chengliang [1 ]
机构
[1] Peoples Hosp Deyang City, Dept Clin Lab, North Taishan Rd 173, Deyang 618000, Sichuan, Peoples R China
[2] Sichuan Univ, Dept Clin Lab, West China Hosp, Chengdu, Peoples R China
[3] Peoples Hosp Deyang City, Dept Rheumatol, Deyang, Peoples R China
关键词
anti-neutrophil cytoplasmic antibody-associated vasculitis; bacterial infection; diagnostic efficacy; disease activity; fibrinogen; renal impairment; COGNITIVE IMPAIRMENT; COAGULATION; FIBRIN(OGEN); ACTIVATION; DISEASE;
D O I
10.1097/MD.0000000000022424
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercoagulable is an important pathological state in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Fibrinogen (FIB) is the main protein in coagulation process. In this study, we aimed to investigate the clinical significance and influencing factors of FIB in AAV from Southwest China. A retrospective study was performed on AAV patients from Peoples Hospital of Deyang City from January 2007 to December 2018. Demographic and clinical characteristics were collected. A total of 463 AAV patients were included. In Wilcoxon rank sum test, FIB was significantly higher in AAV active group than inactive group (P = .005). FIB was also higher in bacterial infection group than in non-infection group both in active group (P = .008) and inactive group (P = .017). In receiver operating characteristic (ROC) curve analysis, the critical value of FIB for diagnosis of bacterial infection between AAV active and inactive groups was 3.385 g/L (P = .030), with sensitivity of 70.2% and specificity of 52.9%. In the multivariate analysis of variance (MANOVA), estimated glomerular filtration rate (eGFR) was shown to be an independent factor for FIB (P = .001). Least-significant difference showed the concentration of FIB (P < .05) increased with renal impairment, especially in endstage kidney disease (ESKD). FIB identified a certain reference value in distinguishing AAV activity from bacterial infection. ESKD had a statistical effect on it. Influencing factors of FIB should be evaluated based on the renal function impairment of patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study
    Samanta, Joydeep
    Naidu, G. S. R. S. N. K.
    Deo, Prateek
    Mittal, Sakshi
    Prasad, Chandra Bhushan
    Das, Diganta
    Dhir, Varun
    Sharma, Shefali Khanna
    Ramachandran, Raja
    Rathi, Manish
    Nada, Ritambhra
    Minz, Ranjana W.
    Jain, Sanjay
    Sharma, Aman
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (12) : 2159 - 2166
  • [32] Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study
    Joydeep Samanta
    GSRSNK Naidu
    Prateek Deo
    Sakshi Mittal
    Chandra Bhushan Prasad
    Diganta Das
    Varun Dhir
    Shefali Khanna Sharma
    Raja Ramachandran
    Manish Rathi
    Ritambhra Nada
    Ranjana W. Minz
    Sanjay Jain
    Aman Sharma
    Rheumatology International, 2022, 42 : 2159 - 2166
  • [33] INTERSTITIAL FIBROSIS IN ANCA-ASSOCIATED VASCULITIS: MPO VERSUS PR3: A SINGLE-CENTER EXPERIENCE
    Benito-Garcia, Silvia
    Marco Rusinol, Helena
    Arce, Yolanda
    Arana Aliaga, Carolt
    Silva, Irene
    Bardaji, Beatriz
    Guirado, Lluis
    Vilardell Vila, Jordi
    Guillen-Gomez, Elena
    Diaz Encarnacion, Montserrat Mercedes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I174 - I174
  • [34] Plasmapheresis Therapy in ANCA-Associated Vasculitides: A Single-Center Retrospective Analysis of Renal Outcome and Mortality
    Solar-Cafaggi, David
    Atisha-Fregoso, Yemil
    Hinojosa-Azaola, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S780 - S781
  • [35] Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality
    Solar-Cafaggi, David
    Atisha-Fregoso, Yemil
    Hinojosa-Azaola, Andrea
    JOURNAL OF CLINICAL APHERESIS, 2016, 31 (05) : 411 - 418
  • [36] OUTCOMES IN ANCA-ASSOCIATED VASCULITIS - A 40 YEAR RETROSPECTIVE COHORT STUDY
    Arulkumaran, Nishkantha
    McAdoo, Stephen
    Kang, Amy
    Antonelou, Marilina
    Tanna, Anisha
    West, Stephen
    Montomoli, Marco
    Gaskin, Gill
    Salama, Alan
    Pusey, Charles
    RHEUMATOLOGY, 2017, 56 : 20 - 21
  • [37] Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study
    Wilding, Anna
    Smith, Rona
    Jayne, David
    Segelmark, Marten
    Mohammad, Aladdin J.
    RMD OPEN, 2024, 10 (02):
  • [38] Childhood onset ANCA-associated vasculitis: retrospective experience in single tertiary centre
    Khan, Zahoor Elahi
    Chieng, Alice
    Willis, Emily
    Riley, Phil
    McDonagh, Janet
    RHEUMATOLOGY, 2019, 58 : 15 - 15
  • [39] Kinetics of B Cell Repopulation After Rituximab in ANCA-Associated Vasculitis: Clinical Significance and Predictive Factors
    Mescia, Federica
    Salviani, Chiara
    Affatato, Stefania
    Tonoli, Mattia
    Guerini, Alice
    Tedesco, Martina
    Moratto, Daniele
    Gregorini, Gina A.
    Chiarini, Marco
    Scolari, Francesco
    Alberici, Federico
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 191 - 191
  • [40] CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN AN ARGENTINIAN COHORT WITH ANCA-ASSOCIATED VASCULITIS
    Perez, Nicolas
    de los Angeles Gargiulo, Maria
    Suarez, Lorena
    Khoury, Marina
    Gomez, Graciela
    MEDICINA-BUENOS AIRES, 2021, 81 (02) : 198 - 207